A big thank you to the World Veterinary Association (WVA), the Federation of Veterinarians of Europe (FVE) and the Federation of Companion Animal Francophone Veterinary Associations (FAFVAC), which have all co-signed our Position Statement
on equal access to veterinary therapeutics for veterinarians around the world.
We’re also delighted to introduce the Chair of our new Therapeutics Guidelines Group (TGG), Dr Luca Guardabassi DVM, PhD, ECVPH, Professor of One Health Antimicrobial Resistance at the University of Copenhagen, Denmark. Dr Guarabassi and his team will be spearheading our campaign to secure equal access.
Luca says: “Difficulty in accessing therapeutics to treat patients is a critical issue for companion animal veterinarians in many parts of the world. It causes huge frustration and means that many thousands – probably millions - of animals do not receive optimum care. It’s a situation which requires urgent change and we are determined to bring this about.
“We’re delighted that so many of our fellow veterinary associations, as well as ten WSAVA member associations, have already endorsed our Position Statement and hope that many more will soon join us in helping to push for urgent change. We’re currently planning the next steps in our campaign so stay tuned!”
Read the full press release in English
Read it in Spanish
Read it in Portugese
Nigeria is one of many countries affected by restricted access to veterinary therapeutics. Dr Olatunji Nasir, Vice President of the Small Animal Veterinary Association of Nigeria and Medical Director and CEO of the Truthmiles Animal Hospital in south west Nigeria, explains why our campaign is so important:
“We face a Herculean task in trying access everything from basic medical consumables, such as syringes and needles, right up to veterinary drugs. Registration fees are very high because they are the equivalent of what is charged for human drugs despite the fact that the volume used is much lower. The process of registering a new drug can also take up to 36 months which feeds demand for sub-standard products which are smuggled into the country. The procedures for importing drugs are also cumbersome and impractical.”